Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC ...Middle East

OSLO, Norway, Feb. 20, 2023 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces the presentation of clinical data from the Veterans Affairs (VA) BRAVO study at the ASCO Genitourinary Cancers Symposium (ASCO GU) which was held February 16-18, 2023 in San Francisco, USA....

Hence then, the article about clinical data presented at asco gu demonstrates reduced risk of recurrence in non muscle invasive bladder cancer with the use of blc was published today ( Monday 20/02/2023 - 10:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC )

Also on site :

• U.S. accuses Iran’s government of operating hacktivist group that hacked Stryker
• King Alfred evacuated as fire crews battle blaze
• ‘The Comeback’ Incited Public Confusion While Recreating 2023 Strikes Outside WB Lot: “Cars Were Honking”